Literature DB >> 22272577

The experience of being diagnosed with hypertrophic cardiomyopathy through family screening in childhood and adolescence.

Ewa-Lena Bratt1, Carina Sparud-Lundin, Ingegerd Ostman-Smith, Asa B Axelsson.   

Abstract

AIM: To describe the experiences of children and adolescents being screened positive for hypertrophic cardiomyopathy and how this impacts their daily life.
BACKGROUND: Hypertrophic cardiomyopathy is a hereditary disease and the most common medical cause of sudden death in childhood and adolescence. This is the reason for recommending screening in children with an affected first-degree relative. A diagnosis of hypertrophic cardiomyopathy implies lifestyle modifications, restrictions that may bring profound changes to the daily life of the affected individual.
DESIGN: This is a descriptive qualitative interview study.
METHODS: We interviewed 13 asymptomatic children or adolescents diagnosed with hypertrophic cardiomyopathy through family screening 12-24 months after the diagnosis. Analysis was conducted with qualitative content analysis.
RESULTS: Children described an involuntary change, which affected their daily life with limitations and restrictions in life, both in the individual and social context. Lifestyle recommendations had the most severe impact on daily life and affected their social context. They tried to navigate in a world with new references, and after reorientation they felt hope and had faith in the future.
CONCLUSIONS: Children diagnosed with hypertrophic cardiomyopathy through family screening went through an involuntary change resulting in limitations and restrictions in life. This study indicates that there is a need for support and that healthcare professionals have to consider the specific needs in these families. Our findings thus give guidance in how best to improve support to the patients and their family. Diagnosis in asymptomatic children should be accompanied by ideally multi-professional follow-up, focusing not only on medical issues.

Entities:  

Mesh:

Year:  2012        PMID: 22272577     DOI: 10.1017/S1047951111002101

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  4 in total

Review 1.  Children's experiences of congenital heart disease: a systematic review of qualitative studies.

Authors:  Lauren S H Chong; Dominic A Fitzgerald; Jonathan C Craig; Karine E Manera; Camilla S Hanson; David Celermajer; Julian Ayer; Nadine A Kasparian; Allison Tong
Journal:  Eur J Pediatr       Date:  2018-01-11       Impact factor: 3.183

Review 2.  The under reporting of recruitment strategies in research with children with life-threatening illnesses: A systematic review.

Authors:  Briony F Hudson; Linda Jm Oostendorp; Bridget Candy; Victoria Vickerstaff; Louise Jones; Monica Lakhanpaul; Myra Bluebond-Langner; Paddy Stone
Journal:  Palliat Med       Date:  2016-09-08       Impact factor: 4.762

3.  Use of Photovoice to Explore Pediatric Patients with Hypertrophic Cardiomyopathy and their Parents' Perceptions of a Heart-Healthy Lifestyle.

Authors:  Frances Sobierajski; Kate Storey; Melissa Bird; Samantha Anthony; Sarah Pol; Tara Pidborochynski; Diana Balmer-Minnes; Alliya Remtulla Tharani; Alyssa Power; Michael Khoury; Chentel Cunningham; Aamir Jeewa; Jennifer Conway
Journal:  J Am Heart Assoc       Date:  2022-03-18       Impact factor: 6.106

4.  Genetic association between 1425G/A SNP in PRKCH and hypertrophic cardiomyopathy in a Chinese population.

Authors:  Feng Ji; Qun Liu; Zeyu Feng; Xinwei Han; Zhitong Li
Journal:  Oncotarget       Date:  2017-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.